SUMIT K. SUBUDHI to Melanoma
This is a "connection" page, showing publications SUMIT K. SUBUDHI has written about Melanoma.
Connection Strength
0.157
-
Improving the therapeutic benefits of ipilimumab. Oncology (Williston Park). 2010 Dec; 24(14):1288, 1294.
Score: 0.115
-
Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe". Immunobiology. 2012 Jun; 217(6):590-2.
Score: 0.031
-
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers. Clin Cancer Res. 2019 02 15; 25(4):1233-1238.
Score: 0.012